Association of Psychological Distress in Patients With Lung Cancer
Launched by SHANGHAI CHEST HOSPITAL · Jan 12, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how psychological distress, which includes feelings like anxiety and depression, affects patients with lung cancer who are receiving treatment. Researchers want to understand if reducing this psychological distress can help improve the effectiveness of cancer therapies, such as immunotherapy and targeted therapy. By studying the connection between emotional well-being and treatment outcomes, the goal is to find ways to help patients manage their mental health during their cancer journey.
To join the trial, participants must be at least 18 years old and have a confirmed diagnosis of lung cancer. They also need to be willing to sign a consent form to participate. The trial is currently recruiting participants, and those who take part will have the opportunity to contribute to important research that could lead to better care for future lung cancer patients. Overall, this study aims to improve both the mental and physical health of individuals facing this challenging diagnosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histologically proven diagnosis of lung cancer
- • 18 years of age or older
- • Ability to understand and the willingness to sign a written informed consent document
- Exclusion Criteria:
- • Not willing to participate in this clinical trial
About Shanghai Chest Hospital
Shanghai Chest Hospital is a leading medical institution in China, renowned for its specialized expertise in respiratory and thoracic diseases. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and improving patient outcomes through innovative therapies and treatments. With a strong emphasis on collaboration and scientific rigor, Shanghai Chest Hospital actively engages in a variety of clinical trials aimed at exploring novel interventions and enhancing the understanding of pulmonary health. The hospital's state-of-the-art facilities and commitment to patient-centered care position it as a key player in the global research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported